NCT03538028 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03538028
Title	A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Incyte Biosciences International Sàrl
Indications	colorectal cancer stomach cancer endometrial cancer lung non-small cell carcinoma renal cell carcinoma lung small cell carcinoma gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma transitional cell carcinoma hepatocellular carcinoma cervical cancer melanoma esophageal cancer triple-receptor negative breast cancer malignant mesothelioma Merkel cell carcinoma ovarian cancer diffuse large B-cell lymphoma
Therapies	INCAGN02385
Age Groups:	adult \| senior
Covered Countries	USA

Facility	City	State	Zip	Country	Details
The Angeles Clinic and Research Center	Los Angeles	California	90025	United States	Details
Hackensack Medical Center	Hackensack	New Jersey	07601	United States	Details
Carolina BioOncology Institute	Huntersville	North Carolina	28078	United States	Details
Vanderbilt University Medical Center	Nashville	Tennessee	37232	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT03538028Clinical Trial Detail